The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

The covid wave this winter is less severe compared with previous years, with hospitalization rates down and wastewater levels ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a ...

Tis the season—for the flu, COVID, stomach bugs, and other nasty viruses that can knock us down for several days, causing ...

“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, there is no vaccine approved to simultaneously protect against both viral ...

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

COVID-19 has been more prevalent and has caused more deaths than flu or respiratory syncytial virus (RSV) in the last three years, according to a study on American veterans published Monday in JAMA ...

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The Health Protection Surveillance Centre (HPSC) has reported a further reduction in cases of flu, the Respiratory Syncytial ...

This winter, flu hospitalizations are rising in parts of the country. Meanwhile, COVID hospitalizations are falling, with ...

and 0.9% for COVID versus 0.7% for both flu and RSV during the 2023-2024 season, reported Kristina L. Bajema, MD, of the Veterans Affairs Portland Health Care System in Oregon, and colleagues.